Responses
Oncolytic and local immunotherapy
Original research
Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade
Compose a Response to This Article
Other responses
No responses have been published for this article.
